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This clinical study assessed and compared the efﬁcacy of tea tree oil (TTO), an alternative form of
medicine, with clotrimazole (i.e., allopathy) and a conservative form of management in the treatment of
oral fungal infection.
In this interventional, observational, and comparative study, we enrolled 36 medically ﬁt individuals of
both sexes who were aged 20e60 years old. The participants were randomly assigned to three groups.
Group I was given TTO (0.25% rinse) as medicament, Group II was given clotrimazole, and Group III was
managed with conservative treatment. The results were analyzed from the clinical evaluation of lesions,
changes in four most common clinical parameters of lesions, and subjective symptoms on periodic
follow-up. Based on the results, the percentage efﬁciency of the two groups were taken and compared
through a bar graph on the scale of 1.
No toxicity to TTO was reported. Group I (TTO) was found to be more efﬁcient than the other two
groups, as changes in four parameter indices of lesions were noted, and results for all three groups were
compared on a percentage basis.
The study concluded that TTO, being a natural product, is a better nontoxic modality compared to
clotrimazole, in the treatment of oral fungal infection and has a promising future for its potential
application in oral health products.
Copyright © 2015, Center for Food and Biomolecules, National Taiwan University. Production and hosting
by Elsevier Taiwan LLC. All rights reserved.1. Introduction
Tea tree oil (TTO) is derived from the paper bark tea tree, which
belongs to the family of Myrtaceae; it belongs to two genera, Lep-
tospermum and Melaleuca.1 TTO medications have been used for
thousands of years by Australian aborigines both internally and
externally for alleviation of pain and promotion of wound healing,
cure colds, and inﬂuenza. Although tree tea oil is used around the
world in a small number of cosmetic and medicinal products, its
use as an ingredient of oral health care products remains limited.
1.8-Cineole and terpinen-4-ol are the main active ingredients of
TTO.2e4 TTO is a uniquely deﬁned combination of monoterpenes,
sesquiterpenes, and terpene alcohol with outstanding therapeutichsil Dhand, Kukas, NH-11 C,
u).
for Food and Biomolecules,
molecules, National Taiwan Univeproperties. It is recognized as having broad-spectrum antibacte-
rial,5 antiviral (Carson et al 2005)6, antimycoplasmal, and anti-
protozoal activities (Furneri et al, 2006)7, as well as anti-
inﬂammatory (Finlay-Jones et al 2001)8 and anticancer properties
(Greay et al 2010).9,10 It acts by damaging the microorganisms'
cellular membrane and subsequently denaturing the cell contents.5
Anecdotally, TTO is known as an excellent treatment for fungal
infections, in particular, vaginal candidiasis and dermatophytoses,
but relative data showing its oral antifungal property is rather
sparse.11e131.1. Aims and objectives
The potential usefulness of TTO in oral health care products has
not been assessed, and hence, through this study, our aim was to
assess and compare the efﬁcacy of TTO as an alternative form of
medicinewith clotrimazole (i.e., allopathy) and a conservative form
of management in the treatment of oral fungal infection. Our
objective was to create directly comparable and quantitativersity. Production and hosting by Elsevier Taiwan LLC. All rights reserved.
Fig. 1. (A) Fungal infection in the palatal region e pre treatment. (B) First visit e After 1
week erythema & burning sensation reduced e Tea tree oil treated. (C) Second visit e
After 2 weeks complete relief.
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which can be a useful addition to the current range of oral anti-
fungal drugs.
2. Materials and methods
The Maharaj Vinayak Global University (MVGU) Research Ethics
Committee gave ethical approval for the study. Patients visiting the
Oral Medicine Department of Jaipur Dental College, Kukas, India
were screened for oral fungal infection. Fungal infection included:
(1) leukoplakia superimposed candidiasis, (2) denture-induced
candidiasis, and (3) pseudomembranous candidiasis. The most
common presenting clinical features of the above-mentioned
fungal infections included erythema (sign), burning sensation
(symptom), inﬂammation (sign), and fungal hyphae (pathological)
as suggested in the literature.8e10 The efﬁciency of the three groups
was compared on the basis of four parameter indices that were
selected based on the most common clinical features of fungal
infection mentioned so far in the literature.
The inclusion criteria called for male and female participants
who were: (1) willing to cooperate, (2) available for regular follow-
up, and (3) within the age group of 20e60 years. The exclusion
criteria included patients who were: (1) uncooperative, (2) on
antifungal medication, (3) HIV-positive, (4) known to have critical
diseases (e.g., leukemia and lymphoma), (5) undergoing radiation
therapy, and those (6) who discontinued the medication and
follow-up and (7) have reported side effects from TTO. Histopath-
ological smear of the lesion and the prosthesis used were taken to
conﬁrm the diagnosis of fungal infection. Patients diagnosed with
fungal infection were randomly divided into (1) TTO group, (2)
Allopathy group (i.e., clotramizole), and (3) Conservative group,
based on the treatment to be carried out.
Evaluation of lesion was done on the basis of four parameter
indices: (1) erythema; (2) visual analog scale, burning sensation;
(3) inﬂammation; and (4) fungal hyphae pretreatment. Complete
medical, drug, and any allergy history were noted for selected pa-
tients, and any subjective and objective symptoms associated with
the lesion were also recorded. Prestructured performa was ﬁlled
with all the above details and with speciﬁc emphasis on the fre-
quency of use of prosthesis and its maintenance.
After the conﬁrmation of the diagnosis, treatment was started,
and those patients whowerewilling to undergo treatment signed a
consent form. During their ﬁrst visit, participants selected for
treatment with Group I were instructed to perform on-spot rinse
with TTO and were placed on a 24-hour observation for any toxic
effect from the essential oil. The participants were handed a
pamphlet thatoutlined theuse of TTO, in the formof a rinse (diluting
5 ml oil/50 ml water e concentration 0.10%) to be done thrice daily
until the ﬁrst follow-up (after a meal). Patients were instructed not
to eat/drink anything until 30 minutes after rinsing. Patients
selected for treatment under Group II (Allopathy) had to apply clo-
trimazole ointment thrice daily after meals until the ﬁrst follow-up.
Under Group III (conservative management), participants were
asked to carry out regular cleaning andwashing of the prosthesis on
a daily basis and removal of prosthesis during the night in case
fungal infection turned out to be denture-induced. The participants
were asked to refrain from using proprietary mouthwashes during
the study, and no auxiliary cleaning aids were allowed to be used
during the course of the study. Medication was distributed to the
participants in labeled (A, TTO; B, Allopathy) dispensing bottles. The
participants were not aware of the contents of these bottles.
Follow-up was carried out after the 1st week, 2nd week, and 3rd
week to evaluate the subsequent changes in the lesion on the basis
of the four parameter indices (Fig. 1AeC). On the recall visit, any
changes in clinical features associated with lesions were noted.Patient performa posttreatment was ﬁlled up again, and the
medication was continued if any symptoms and signs of the lesion
persisted. No patient reported any adverse effects in relation with
the oil. The recorded data were preserved for analysis of results.
Table 2
Percentage efﬁciency of each group in treatment of all four parameter indices.
Indices TTO Clotriamazole Cons
Erythema 89% 71% 40%
VAS 100% 100% 50%
Inﬂammation 85.70% 80.00% 66.67%
Hyphae 85.70% 100% 100%
Data are presented as %.
TTO ¼ tea tree oil; VAS ¼ visual analog scale.
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The data for each participant were added, averaged, and
weighted depending on the positive (improvement) or negative (no
improvement) changes in the lesion in subsequent recalls. The ef-
ﬁciency, compliance, and safety index of the two drugs were
evaluated and compared using a relative percentage chart for both
groups. Results were analyzed using bargraph for all clinical
indices. The efﬁciency of all three treatment methods was
compared on a bar graph on the scale of 1.
3. Results and discussion
A total of 36 participants, consisting of 11 females and 25 males
(Table 1), were recruited for the study. Those not included in the
study were either dropouts or were omitted based on the exclusion
criteria. Statistical analysis showed that intraexaminer error was
within acceptable limits. Overall, there were 13 patients in Group I,
13 patients in Group II, and 10 patients in Group III.
A percentage analysis for all three groups was done, and a
comparative chart in terms of percentage for all four parameter
indices (Table 2) was drawn up.
The following results were deduced (Table 2). (1) The TTO-
treated group showed an 89% reduction in erythema and inﬂam-
mation compared to the other two groups. Thus, TTO proved to be a
better alternative to clotrimazole in reducing the two main clinical
features associated with oral fungal infection. (2) In the TTO group,
there was a 100% reduction in visual analog scale burning sensation
score. A complete elimination of fungal hyphae was achieved only
by clotrimazole. Clotrimazole proved to be 100% successful in the
reduction of clinical and histopathological features in this study.
100% reduction in burning sensation was achieved in subjects
treated under group I & group II, but only 50% reduction was ach-
ieved in group III.
From the above ﬁndings, it was preliminarily concluded that
overall both Group I and Group II are at par in giving symptomatic
relief to patients suffering from oral fungal infection.
As the study was directed toward comparing allopathy and
alternative medicine in the treatment of oral fungal infection, we
further ﬁltered the results and compared all three modalities
through a bar graph on the scale of 1 (Fig. 2).
A bar graph analysis was performed to determine the most
efﬁcient modality. It showed the following results. (1) TTO (Group I)
was the most efﬁcient of all three modalities. (2) Although clotri-
mazole (Group II) scored 100% on two indices, it came only a close
second in overall efﬁciency. (3) Conservative management (Group
III) was the least efﬁcient of all three treatments.
The allopathic antifungal agents are effective in the treatment of
oral fungal infection, but present several major negative effects that
cannot be overlooked. Polyene antifungals have a broad spectrum
of antifungal activities, but because of their poor absorption
through the gut their use in the treatment of oral candidiasis is
limited. Fewer cases of polyene toxicity to animal cells have been
reported; however, at therapeutic doses, some (e.g., amphotericin
B) may bind to animal membrane cholesterol, thus increasing the
risk of human toxicity. Amphotericin B is also nephrotoxic whenTable 1
Distribution in treatment groups of subjects by age and gender.
Group Female Male n Mean age (y)
TTO 5 8 13 64.92
Clotriamazole 4 9 13 63.24
Cons 2 8 10 64.51
TTO ¼ tea tree oil.given intravenously. Some recent case reports also suggest the
toxicity of nystatin if it is used in the long run. As a polyene's hy-
drophobic chain is shortened, its sterol binding activity is increased.
Therefore, further reduction of the hydrophobic chain may result in
it binding to cholesterol, making it toxic to humans. Among azole
antifungals, ﬂuconazole is the agent of ﬁrst choice for all forms of
oral candidosis. However, several mechanisms of azole resistance
have been reported including: (1) an alteration in the chemical
structure of the demethylase enzyme, (2) removal of the azole from
the cell by multidrug transporter pumps, and (3) compensation by
other sterol synthesis enzymes in membrane biosynthesis.14 These
resistance mechanisms of fungal microorganisms can increase the
chances of failure of these antifungal drugs in the future. The
clinical effectiveness of agents that can only be delivered topically,
such as amphotericin or nystatin, is limited owing to problems in
maintaining sufﬁcient levels of these drugs at the site of infection.
The taste of topical agents stimulates salivary secretion, which
rapidly dilutes and removes the antifungal agent from the mouth.
In view of this, their clinical use is limited (K. Hammer et al 2002).15
Fluconazole has a good safety proﬁle when given systemically, with
few contraindications or side effects. Important interactions occur
with coumarin anticoagulants and sulfonylurea antidiabetic agents
though. Apart from certain side effects such as liver damage or
effect on estrogen levels, many antifungal medicines can cause
allergic reactions in some people. For example, the azole group of
drugs is known to have caused anaphylaxis.16
Hence, allopathic antifungals is beneﬁcial but also has several
major side effects. In vitro studies regarding TTO have been per-
formed on ﬁlamentous fungi, dermatophytes, and Candida albicans.
The literature suggests that TTO in vitro substantially alters the
membrane permeability of C. albicans and Candida glabrata. TTO is
also less misicible in water compared to clotramizole. Therefore,
compared to clotramizole TTO will be less misicible in saliva and
will remain at the effected site for a longer length of time, thereby
producing a better pharmacological effect. As discussed in detail,Fig. 2. Bar graph analysis of indices for every group. Results: 1. TTO is effective in
reducing inﬂammation and erythema better than other two modalities. 2. Clo-
triamazole is equally at a par with TTO in reducing irritation and VAS score. 3. Con-
servative Management is equally at a par with the other two modalities in reducing
irritation and hyphae and less effective in reducing inﬂammation, VAS, and erythema.
TTO ¼ tea tree oil; VAS ¼ visual analog scale.
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long run, whereas TTO, being purely a herbal plant, has no toxic
effects if used for a long duration.17,18
3.1. Limitations
Although the authors have tried their best to include all possible
parameters in the study, certain limitations/drawbacks remain (as
detailed below).
Research can be elaborated with an increase in the sample size
with special emphasis on a speciﬁc candidal pathogen that is
mainly the causative factor for denture-induced candidiasis.
As candida is one of the predisposing factors for potentially
premalignant and malignant lesions, speciﬁc Candida species can
be investigated.
The efﬁcacy of TTO can be compared on the different grades of
denture-induced candidiasis.
The future of tea trees is interesting and challenging, and more
aspects of its properties and potential therapeutic applications can
be investigated.
4. Conclusion
Within the limitations of the study, it was apparent that Group I
patients showed improvement in relation to symptoms associated
with lesion(s). TTO, being a better alternative to clotrimazole, is
justiﬁable because it has good membrane permeability and has no
toxic effects, whereas allopathic antifungals have several side ef-
fects that cannot be overlooked. From the study results, we
conclude that efﬁciency of both medications are at a par, but TTO,
being nontoxic, economical, and compliable, remains a better
alternative to allopathy in the treatment of oral fungal infections.
The components of TTO are known to have lipophilic properties
that facilitate its diffusion through the epithelium. If TTO is readily
absorbed after its topical application or rinse into gingival tissues
and has antifungal properties once it has entered connective tis-
sues, it would be a unique nontoxic agent that would be a useful
addition to the current range of chemotherapeutic antifungal
options.
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